These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34310279)

  • 1. Autoregulatory control of microtubule binding in doublecortin-like kinase 1.
    Agulto RL; Rogers MM; Tan TC; Ramkumar A; Downing AM; Bodin H; Castro J; Nowakowski DW; Ori-McKenney KM
    Elife; 2021 Jul; 10():. PubMed ID: 34310279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and Structural Insights into Doublecortin-like Kinase Domain 1.
    Patel O; Dai W; Mentzel M; Griffin MD; Serindoux J; Gay Y; Fischer S; Sterle S; Kropp A; Burns CJ; Ernst M; Buchert M; Lucet IS
    Structure; 2016 Sep; 24(9):1550-61. PubMed ID: 27545623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1.
    Weygant N; Qu D; Berry WL; May R; Chandrakesan P; Owen DB; Sureban SM; Ali N; Janknecht R; Houchen CW
    Mol Cancer; 2014 May; 13():103. PubMed ID: 24885928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical Biology Toolkit for DCLK1 Reveals Connection to RNA Processing.
    Liu Y; Ferguson FM; Li L; Kuljanin M; Mills CE; Subramanian K; Harshbarger W; Gondi S; Wang J; Sorger PK; Mancias JD; Gray NS; Westover KD
    Cell Chem Biol; 2020 Oct; 27(10):1229-1240.e4. PubMed ID: 32755567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DCLK1 phosphorylates the microtubule-associated protein MAP7D1 to promote axon elongation in cortical neurons.
    Koizumi H; Fujioka H; Togashi K; Thompson J; Yates JR; Gleeson JG; Emoto K
    Dev Neurobiol; 2017 Apr; 77(4):493-510. PubMed ID: 27503845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for small molecule targeting of Doublecortin Like Kinase 1 with DCLK1-IN-1.
    Patel O; Roy MJ; Kropp A; Hardy JM; Dai W; Lucet IS
    Commun Biol; 2021 Sep; 4(1):1105. PubMed ID: 34545159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional implication of Dclk1 and Dclk1-expressing cells in cancer.
    Westphalen CB; Quante M; Wang TC
    Small GTPases; 2017 Jul; 8(3):164-171. PubMed ID: 27458755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluvastatin interferes with hepatitis C virus replication via microtubule bundling and a doublecortin-like kinase-mediated mechanism.
    Ali N; Allam H; Bader T; May R; Basalingappa KM; Berry WL; Chandrakesan P; Qu D; Weygant N; Bronze MS; Umar S; Janknecht R; Sureban SM; Huycke M; Houchen CW
    PLoS One; 2013; 8(11):e80304. PubMed ID: 24260365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic Landscape and Therapeutic Implication of Gene Isoforms of Doublecortin-Like Kinase 1 for Cancer Stem Cells.
    Moore LL; Houchen CW
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of doublecortin-like kinase 1 inhibitors and their bioactivity evaluation.
    Pan P; Ji D; Li Z; Meng X
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2287990. PubMed ID: 38062554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Mechanism of Mutational Disruption of DCLK1 Autoinhibition Provides a Rationale for Inhibitor Screening.
    Chen W; Liu R; Yu Y; Wei D; Chen Q; Xu Q
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doublecortin-Like Kinase 1 Facilitates Dendritic Spine Growth of Pyramidal Neurons in Mouse Prefrontal Cortex.
    Murphy KE; Zhang EY; Wyatt EV; Sperringer JE; Duncan BW; Maness PF
    Neuroscience; 2023 Jan; 508():98-109. PubMed ID: 36064052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doublecortin-like Kinase 1 Regulates α-Synuclein Levels and Toxicity.
    Vázquez-Vélez GE; Gonzales KA; Revelli JP; Adamski CJ; Alavi Naini F; Bajić A; Craigen E; Richman R; Heman-Ackah SM; Wood MJA; Rousseaux MWC; Zoghbi HY
    J Neurosci; 2020 Jan; 40(2):459-477. PubMed ID: 31748376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells.
    Chandrakesan P; Yao J; Qu D; May R; Weygant N; Ge Y; Ali N; Sureban SM; Gude M; Vega K; Bannerman-Menson E; Xia L; Bronze M; An G; Houchen CW
    Mol Cancer; 2017 Feb; 16(1):30. PubMed ID: 28148261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doublecortin-like kinase 1 activates NF-κB to induce inflammatory responses by binding directly to IKKβ.
    Luo W; Jin Y; Jiang Y; Yang L; Xu H; Wu D; Zhang Y; Yin L; Khan ZA; Liang G; Wang Y
    Cell Death Differ; 2023 May; 30(5):1184-1197. PubMed ID: 36914767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a doublecortin-like kinase 1 inhibitor to prevent inflammatory responses in acute lung injury.
    Cai B; Xu Y; Luo R; Lu K; Wang Y; Zheng L; Zhang Y; Yin L; Tu L; Luo W; Zheng L; Zhang F; Lv X; Tang Q; Liang G; Chen L
    Bioorg Chem; 2024 Apr; 145():107215. PubMed ID: 38394920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research Progress of DCLK1 Inhibitors as Cancer Therapeutics.
    Cheng L; Huang S; Chen L; Dong X; Zhang L; Wu C; Ye K; Shao F; Zhu Z; Thorne RF
    Curr Med Chem; 2022; 29(13):2261-2273. PubMed ID: 34254905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer.
    Dogra S; Elayapillai SP; Qu D; Pitts K; Filatenkov A; Houchen CW; Berry WL; Moxley K; Hannafon BN
    Cancer Lett; 2023 Dec; 578():216437. PubMed ID: 37838282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases.
    Ali N; Chandrakesan P; Nguyen CB; Husain S; Gillaspy AF; Huycke M; Berry WL; May R; Qu D; Weygant N; Sureban SM; Bronze MS; Dhanasekaran DN; Houchen CW
    Oncotarget; 2015 Aug; 6(24):20327-44. PubMed ID: 25948779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doublecortin-like kinase 1 promotes hepatocyte clonogenicity and oncogenic programming via non-canonical β-catenin-dependent mechanism.
    Ali N; Nguyen CB; Chandrakesan P; Wolf RF; Qu D; May R; Goretsky T; Fazili J; Barrett TA; Li M; Huycke MM; Bronze MS; Houchen CW
    Sci Rep; 2020 Jun; 10(1):10578. PubMed ID: 32601309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.